Desvarieux M, Hyppolite P R, Johnson W D, Pape J W
Division of Epidemiology, School of Public Health, Department of Medicine, School of Medicine, University of Minnesota, Minneapolis, USA.
Am J Public Health. 2001 Jan;91(1):138-41. doi: 10.2105/ajph.91.1.138.
This study evaluated a novel approach to the delivery of directly observed therapy (DOT) for tuberculosis in Haiti.
A total of 194 patients (152 HIV seropositive, 42 HIV seronegative) received daily unsupervised triple-drug therapy for 4 to 8 weeks, followed by twice-weekly 2-drug therapy for the remainder of the 6-month period. DOT was deferred until initiation of the twice-weekly phase.
A total of 169 of 194 patients (87.1%) completed the 6-month course. The program of deferred DOT had an effectiveness of 85%. Overall cost was reduced by approximately 40%.
Flexible approaches to DOT, integrating behavioral knowledge, cost considerations, and practicality may improve completion rates and program effectiveness.